Peripheral and mesenteric serum levels of CEA and cytokeratins, staging and histophatological variables in colorectal adenocarcinoma

World Journal of Gastroenterology

Volumn 14, Issue 43, 2008, Pages 6699-6703

  Ivankovics, Ivan Gregório ^a   Fernandes, Luis César ^a   Saad, Sarhan Sydeney ^a   Matos, Delcio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biological tumor markers; Carcinoembryonic antigen; Colonic neoplasms; Cytokeratins; Rectal neoplasms

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN; TUMOR MARKER;

ADVANCED CANCER; ARTICLE; CANCER INVASION; CANCER SIZE; CANCER STAGING; CARCINOMA CELL; CELL DIFFERENTIATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE MARKER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MESENTERY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

EID: 63449097050     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.6699     Document Type: Article

References (22)

1. Fernandes LC, Kim SB, Matos D. Cytokeratins and carcinoembryonic antigen in diagnosis, staging and prognosis of colorectal adenocarcinoma. World J Gastroenterol 2005; 11: 645-648
2. Fernandes LC, Kim SB, Saad SS, Matos D. Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer. World J Gastroenterol 2006; 12: 3891-3894
3. Wilmink AB. Overview of the epidemiology of colorectal cancer. Dis Colon Rectum 1997; 40: 483-493
4. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005; 16: 481-488
5. Correale M, Arnberg H, Blockx P, Bombardieri E, Castelli M, Encabo G, Gion M, Klapdor R, Martin M, Nilsson S. Clinical profile of a new monoclonal antibody-based immunoassay for tissue polypeptide antigen. Int J Biol Markers 1994; 9: 231-238
6. Forones NM, Tanaka M, Machado D, Falcão JB, Giovanoni M. [Carcinoembryonic antigen in diagnosis and monitoring of colorectal cancer] Arq Gastroenterol 1997; 34: 3-6
7. Kim SB, Fernandes LC, Saad SS, Matos D. Assessment of the value of preoperative serum levels of CA 242 and CEA in the staging and postoperative survival of colorectal adenocarcinoma patients. Int J Biol Markers 2003; 18: 182-187
8. Lindmark G, Gerdin B, Påhlman L, Bergström R, Glimelius B. Prognostic predictors in colorectal cancer. Dis Colon Rectum 1994; 37: 1219-1227
9. Plebani M, De Paoli M, Basso D, Roveroni G, Giacomini A, Galeotti F, Corsini A. Serum tumor markers in colorectal cancer staging, grading, and follow-up. J Surg Oncol 1996; 62: 239-244
10. Gold P, Freedman SO. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965; 121: 439-462
11. Björklund B. Tissue polypeptide antigen (TPA): Biology, biochemistry, improved assay methodology, clinical significance in cancer and other conditions, and future outlook. Antibiot Chemother 1978; 22: 16-31
12. Tabuchi Y, Deguchi H, Imanishi K, Saitoh Y. Comparison of carcinoembryonic antigen levels between portal and peripheral blood in patients with colorectal cancer. Correlation with histopathologic variables. Cancer 1987; 59: 1283-1288
13. Tabuchi Y, Deguchi H, Imanishi K, Saitoh Y. Carcinoembryonic antigen levels of peripheral and draining venous blood in patients with colorectal cancer. Correlation with survival. Cancer 1992; 69: 2411-2417
14. Harlozinska A, Rachel F, Gawlikowski W, Richter R, Kolodziej J. CEA and NCA levels in peripheral and tumour venous blood of patients with gastric and colonic carcinomas estimated by RIA and EIA methods. Eur J Surg Oncol 1991; 17: 59-64
15. Moura RM, Matos D, Galvão Filho MM, D'Ippólito G, Sjzenfeld J, Giuliano LM. Value of CEA level determination in gallbladder bile in the diagnosis of liver metastases secondary to colorectal adenocarcinoma. Sao Paulo Med J 2001; 119: 110-113
16. Waisberg J, Contim-Neto L, Oliveira Mda S, Matheus Cde O, Nagashima CA, Goffi FS. Determination of carcinoembryonic antigen levels in peripheral and draining venous blood in patients with colorectal carcinoma. Arq Gastroenterol 2004; 41: 88-92
17. Finlay IG, McArdle CS. The identification of patients at high risk following curative resection for colorectal carcinoma. Br J Surg 1982; 69: 583-584
18. Deguchi H, Tabuchi Y, Saitoh Y. [CEA levels of draining venous blood and draining-peripheral CEA gradient in colorectal cancer patients: correlation with postoperative survival] Nippon Geka Gakkai Zasshi 1990; 91: 575-580
19. Finlay IG, Meek DR, Gray HW, Duncan JG, McArdle CS. Incidence and detection of occult hepatic metastases in colorectal carcinoma. Br Med J (Clin Res Ed) 1982; 284: 803-805
20. Koch M, Weitz J, Kienle P, Benner A, Willeke F, Lehnert T, Herfarth C, von Knebel Doeberitz M. Comparative analysis of tumor cell dissemination in mesenteric, central, and peripheral venous blood in patients with colorectal cancer. Arch Surg 2001; 136: 85-89
21. Hünerbein M. The value of tumor markers in colorectal cancer. Recent Results Cancer Res 1998; 146: 48-55
22. Tabuchi Y, Nakamura T, Kuniyasu T. A predictive value of carcinoembryonic antigen in draining venous blood for colorectal cancer patients with postoperative hematogenous metastases. Cancer Detect Prev 1998; 22: 57-61